I. Timofte

发表

A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation

B. Griffith, M. Terrin, A. Iacono, 2019, ERJ Open Research.

Adaptive periodic paralysis allows weaning deep sedation overcoming the drowning syndrome in ECMO patients bridged for lung transplantation: A case series

B. Griffith, J. Menaker, S. Pham, 2017, Journal of critical care.

Diaphragmatic herniation due to massive hepatomegaly in a patient with pulmonary arterial hypertension

G. Ramani, R. Reed, I. Timofte, 2015, BMJ Case Reports.

A case report of breakthrough infections with two SARS-CoV-2 variants in a lung transplant patient

F. Torres, A. Banga, I. Timofte, 2022, Transplantation Proceedings.

The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa.

M. Mackova, D. Kreisel, G. Snell, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants

D. Kreisel, G. Snell, P. Jaksch, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept for renal rescue in lung transplant patients

B. Griffith, R. Pierson, S. Pham, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements.

G. Verleden, R. Domsic, K. Hoetzenecker, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary hypertension before first and second lung transplantation

A. Tonelli, O. Minai, M. Baz, 2012, Clinical transplantation.

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.

G. Berry, P. Shah, J. Orens, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Venous Thromboembolic Complications of Lung Transplantation: A Contemporary Single-Institution Review.

B. Griffith, F. Cheema, S. Pham, 2015, The Annals of thoracic surgery.

Use of immune checkpoint inhibition and conventional chemotherapy for multiple, concurrent malignancies post-lung transplantation: a case report

R. Koka, K. Cullen, N. Mirkheshti, 2022, Current Problems in Cancer: Case Reports.

Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.

P. Shah, S. Aryal, A. Iacono, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss.

D. Kreisel, G. Snell, P. Jaksch, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Molecular assessment of rejection and injury in lung transplant biopsies.

D. Kreisel, E. Trulock, G. Snell, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients.

F. Torres, A. Banga, L. Terada, 2022, Transplantation.

Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD

B. Griffith, A. Sternberg, R. Wise, 2020, ERJ Open Research.

Gait-speed and oxygen flow during six-minute walk test predicts mortality in patients with advanced lung disease

A. Verceles, M. Terrin, A. Tonelli, 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections

F. Torres, A. Banga, I. Timofte, 2022, Transplantation Proceedings.

Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID‐19

F. Torres, A. Banga, L. Terada, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).

P. Shah, J. Orens, K. Khush, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Molecular phenotyping of rejection‐related changes in mucosal biopsies from lung transplants

D. Kreisel, G. Snell, P. Jaksch, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation

S. Quake, G. Berry, H. Valantine, 2019, EBioMedicine.

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.

G. Berry, M. Pirooznia, H. Valantine, 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

CARE Score on Chest Radiograph at Diagnosis Predicts Early and Late Outcomes Among Lung Transplant Patients with COVID-19

A. Banga, K. Batra, I. Timofte, 2022, The Journal of Heart and Lung Transplantation.

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.

H. Valantine, P. Shah, J. Orens, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Molecular Detection of Rejection-like Changes in Proximal Bronchial Mucosal Lung Transplant Biopsies: Initial Findings of the INTERLUNG Study

D. Kreisel, E. Trulock, G. Snell, 2018 .

Defining a NK cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies.

D. Kreisel, G. Snell, P. Jaksch, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tuberous sclerosis complex: multisystem hamartomas

M. McCurdy, R. Reed, I. Timofte, 2015, BMJ Case Reports.

Belatacept for renal rescue in lung transplant patients

B. Griffith, R. Pierson, S. Pham, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Elevated Donor-Derived Cell-Free DNA (ddcfDNA) as an Early Risk Factor for the Development and Persistence of De Novo Donor Specific HLA Antibody

H. Valantine, P. Shah, J. Orens, 2018 .

Molecular assessment of rejection and injury in lung transplant biopsies.

D. Kreisel, E. Trulock, G. Snell, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Spirometry testing for extracorporeal membrane oxygenation (ECMO) bridge to transplant patients

B. Griffith, D. Herr, S. Hines, 2022, Respiratory medicine case reports.